Phil McEwan

Company: Health Economics and Outcomes Research Ltd

Job title: Chief Executive Officer

Seminars:

Securing Payer Buy-In to Enhance Patient Access to Your CKD Treatment 1:30 pm

Strategically analyzing optimal avenues for reimbursement generation post-approval Emphasizing the significance of educating payers on the burden of CKD and the unmet need of existing therapies Establishing robust, evidence-based treatment guidelines, specific to CKD stage or patient subtype, to maximize support from payers and insurersRead more

day: Day 2 Track 3 PM

Panel Discussion | Navigating Payers Perspectives & Moving Towards Surrogate Endpoints to Demonstrate Reimbursement for CKD Patient Populations 1:00 pm

How important is having hard outcomes data vs a surrogate measure of CKD progression or improvement? What will it take to pivot away from hard endpoints to demonstrate convincing evidence of improvements in renal function? What are the clinical evidence requirements from payers and insurers to demonstrate reimbursement and offer effective therapies to CKD patients…Read more

day: Day 2 Track 3 PM